274 evolution "https:" "https:" "https:" "https:" "https:" "https:" positions at University of Colorado in United States
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the AI working group. • Work collaboratively with academic stakeholders across the university to understand and meet the needs for AI tools and professional development. • Work collaboratively with
-
integrity, and publication efforts. Mentor trainees, staff and faculty in research methodology, writing, and professional development. Identify and pursue external funding opportunities through federal
-
position is in a research program focused on the early developmental pathways to auditory development and the influences on perception. By understanding the impact of auditory access on perceptual
-
advance the development of ultrasound based diagnostics for type1 diabetes. The Benninger lab is a multidisciplinary team of scientists and engineers who broadly investigates the cellular and physiological
-
: • Serve as lead budget analyst for Administration, providing expert guidance on budget development and resource allocation. • Mentor and provide technical guidance to junior budget staff. • Represent
-
loans, when required, in a timely manner. Assist with program development and process improvement. Maintain professionalism and responsibility for productivity and quality service delivery. Assist with
-
: – Requisition #:38719 Job Summary: The Soragni Laboratory seeks a Project Scientist with expertise in patient-derived tumor organoids, high throughput assay development, and clinical sample handling. The Project
-
, comprehensive career development, and world-class care. The Division Vision is to be the source of superior healthcare, push boundaries of discovery, advance medical education and create hope for patients with
-
Coordinator Position #: 00756542 – Requisition #: 38723 Job Summary: This position will participate as a member of the Cancer Center’s Oncology Clinical Research Support Team (OCRST) in the development and
-
research (85%) and education/training (15%). The research component will focus on the development and validation of CAR T cell–based therapies designed to eradicate minimal residual disease and treatment